Stem cell transplantation in the treatment of type 1 diabetes mellitus: from insulin replacement to beta-cell replacement

XX Wan, DY Zhang, MA Khan, SY Zheng… - Frontiers in …, 2022 - frontiersin.org
Type 1 diabetes mellitus (T1DM) is an autoimmune disease that attacks pancreatic β-cells,
leading to the destruction of insulitis-related islet β-cells. Islet β-cell transplantation has been …

Alpha-1 antitrypsin: A novel biomarker and potential therapeutic approach for metabolic diseases

X Zhang, DA Ostrov, H Tian - Clinica Chimica Acta, 2022 - Elsevier
It is well recognized that chronic low-grade systemic inflammation and autoimmunity
contribute to the pathogenesis of metabolic syndrome, its associated diseases (eg type 2 …

Stem cell therapy improves human islet graft survival in mice via regulation of macrophages

W Gou, W Hua, L Swaby, W Cui, E Green… - Diabetes, 2022 - Am Diabetes Assoc
Islet/β-cell transplantation offers great hope for patients with type 1 diabetes. We assessed
the mechanisms of how intrahepatic coinfusion of human α-1 antitrypsin (hAAT)-engineered …

BMSCs overexpressed ISL1 reduces the apoptosis of islet cells through ANLN carrying exosome, INHBA, and caffeine

Y Wang, JW Zhang, JW Wang, JL Wang… - Cellular and Molecular …, 2022 - Springer
Early apoptosis of grafted islets is one of the main factors affecting the efficacy of islet
transplantation. The combined transplantation of islet cells and bone marrow mesenchymal …

Proteomic analysis of exosomes secreted from human alpha-1 antitrypsin overexpressing mesenchymal stromal cells

H Wei, E Green, L Ball, H Fan, J Lee, C Strange… - Biology, 2021 - mdpi.com
Simple Summary The overexpression of human alpha-1 antitrypsin (hAAT) in mesenchymal
stromal cells (MSCs) improved their intrinsic properties with enhanced protective effects in …

Immortalized mesenchymal stromal cells overexpressing alpha‐1 antitrypsin protect acinar cells from apoptotic and ferroptotic cell death

S Shoeibi, E Green, H Wei, W Gou… - Journal of Cellular …, 2024 - Wiley Online Library
Chronic pancreatitis (CP) is a progressive inflammatory disorder that impairs endocrine and
exocrine function. Our previous work showed that mesenchymal stem/stromal cells (MSCs) …

A novel cellular therapy to treat pancreatic pain in experimental chronic pancreatitis using human alpha-1 antitrypsin overexpressing mesenchymal stromal cells

RP Chow, K Nguyen, W Gou, E Green, K Morgan… - Biomedicines, 2021 - mdpi.com
Chronic pancreatitis (CP) is characterized by pancreatic inflammation, fibrosis, and
abdominal pain that is challenging to treat. Mesenchymal stromal cells (MSCs) …

Novel insights into the relationship between α-1 anti-trypsin with the pathological development of cardio-metabolic disorders

H Luo, P Wu, X Chen, B Wang, G Chen, X Su - International …, 2022 - Elsevier
According to the previous studies, chronic low-grade systemic inflammatory response has
been shown to be significantly associated with the pathological development of cardio …

Overexpression of Alpha-1 Antitrypsin Increases the Proliferation of Mesenchymal Stem Cells by Upregulation of Cyclin D1

B Wolf, P Muralidharan, MY Lee, W Hua… - International Journal of …, 2024 - mdpi.com
Alpha-1 antitrypsin-overexpressing mesenchymal stromal/stem cells (AAT-MSCs) showed
improved innate properties with a faster proliferation rate when studied for their protective …

Therapeutic Strategies Targeting Pancreatic Islet β-Cell Proliferation, Regeneration, and Replacement

RA Goode, JM Hum, MA Kalwat - Endocrinology, 2023 - academic.oup.com
Diabetes results from insufficient insulin production by pancreatic islet β-cells or a loss of β-
cells themselves. Restoration of regulated insulin production is a predominant goal of …